Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tor B Stuge

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Women'S Health|May 2, 2017
Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunitiesHeidi Tiller, Anne Husebekk, Maria Therese Ahlen, et al.
Blood|January 13, 2009
T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cellsMaria Therese Ahlen, Anne Husebekk, Mette Kjaer Killie, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 29, 2011
The cellular immunobiology associated with fetal and neonatal alloimmune thrombocytopeniaTor B Stuge, Bjørn Skogen, Maria Therese Ahlen, et al.
Scandinavian Journal of Immunology|April 17, 2020
The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypesMaria Therese Ahlen, Gøril Heide, Anne Husebekk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2016
A Leukocyte Immune-Type Receptor Subset Is a Marker of Antiviral Cytotoxic Cells in Channel Catfish, Ictalurus punctatusErin B Taylor, Mohadetheh Moulana, Tor B Stuge, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responsesHolbrook E Kohrt, Chen-Tsen Shu, Tor B Stuge, et al.
Plos Medicine|December 4, 2004
Diversity and recognition efficiency of T cell responses to cancerTor B Stuge, Susan P Holmes, Sahdev Saharan, et al.
Expert Review of Hematology|November 19, 2010
Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and preventionBjørn Skogen, Mette Kjær Killie, Jens Kjeldsen-Kragh, et al.
Nature Medicine|October 7, 2003
Ex vivo identification, isolation and analysis of tumor-cytolytic T cellsValerie Rubio, Tor B Stuge, Naileshni Singh, et al.
Journal of Translational Medicine|July 29, 2011
Cytotoxic T lymphocyte responses against melanocytes and melanomaGwendolen Y Chang, Holbrook E Kohrt, Tor B Stuge, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Women'S Health|May 2, 2017
Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunitiesHeidi Tiller, Anne Husebekk, Maria Therese Ahlen, et al.
Blood|January 13, 2009
T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cellsMaria Therese Ahlen, Anne Husebekk, Mette Kjaer Killie, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 29, 2011
The cellular immunobiology associated with fetal and neonatal alloimmune thrombocytopeniaTor B Stuge, Bjørn Skogen, Maria Therese Ahlen, et al.
Scandinavian Journal of Immunology|April 17, 2020
The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypesMaria Therese Ahlen, Gøril Heide, Anne Husebekk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2016
A Leukocyte Immune-Type Receptor Subset Is a Marker of Antiviral Cytotoxic Cells in Channel Catfish, Ictalurus punctatusErin B Taylor, Mohadetheh Moulana, Tor B Stuge, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responsesHolbrook E Kohrt, Chen-Tsen Shu, Tor B Stuge, et al.
Plos Medicine|December 4, 2004
Diversity and recognition efficiency of T cell responses to cancerTor B Stuge, Susan P Holmes, Sahdev Saharan, et al.
Expert Review of Hematology|November 19, 2010
Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and preventionBjørn Skogen, Mette Kjær Killie, Jens Kjeldsen-Kragh, et al.
Nature Medicine|October 7, 2003
Ex vivo identification, isolation and analysis of tumor-cytolytic T cellsValerie Rubio, Tor B Stuge, Naileshni Singh, et al.
Journal of Translational Medicine|July 29, 2011
Cytotoxic T lymphocyte responses against melanocytes and melanomaGwendolen Y Chang, Holbrook E Kohrt, Tor B Stuge, et al.
Pageof 3